Pranitha Patil, co-founder and chief business officer of the preventive health membership platform Function, has seen her startup reach a valuation of $2.5 billion. Founded alongside Jonathan Swerdlin, Dr. Mark Hyman, Seth Weisfeld, and Dan Swerdlin, Function offers its members over 160 lab tests, advanced imaging services, and AI-driven insights, all for an annual fee of $365. This cost is notably lower than the typical $15,000 required for similar testing purchased independently.
Patil’s journey to founding Function began long before its official launch in 2021. Having faced personal health challenges, including polycystic ovary syndrome and pre-diabetes, she recognized a gap in the healthcare system that often leaves patients feeling isolated in managing their health. Her experiences prompted her to create a platform that emphasizes proactive health management rather than reactive treatment.
While studying for a master’s degree in design engineering at Harvard, Patil met CEO Jonathan Swerdlin and decided to pursue her vision of a comprehensive preventive health platform, ultimately leaving her studies to focus on Function. The founders aimed to provide continuous health monitoring through lab testing and advanced data analytics.
Early on, convincing investors of the long-term potential of Function posed challenges. However, the team successfully communicated their vision, leading to significant investment and expansion opportunities. They plan to integrate AI technologies to enhance user experience and streamline health management, aiming to reach a global audience of eight billion.
As Function moves into what Patil refers to as its second act, the company focuses on increasing accessibility to preventative health solutions, underlining its commitment to empowering individuals in their health journeys.
Why this story matters
- It highlights innovative approaches in preventive healthcare that could reshape health management.
Key takeaway
- Function’s model emphasizes proactive health monitoring, offering a cost-effective alternative to traditional medical testing.
Opposing viewpoint
- Critics may argue that reliance on AI and technology could overlook the personal, human aspects of healthcare.
